Pacira BioSciences, Inc. PCRX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Pacira BioSciences, Inc.’s reported figures.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s free cash flow?
- Pacira BioSciences, Inc. (PCRX) reported free cash flow of $22.96M in Q1 2026.
- How has Pacira BioSciences, Inc.'s free cash flow changed year-over-year?
- Pacira BioSciences, Inc.'s free cash flow decreased by 14.7% year-over-year, from $26.91M to $22.96M.
- What is the long-term trend for Pacira BioSciences, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Pacira BioSciences, Inc.'s free cash flow has grown at a 14.4% compound annual growth rate (CAGR), from $79.85M to $136.66M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.